Data Analysis of PSA Levels and Age-Wise Distribution of Various Lesions Histopathological Corelation

Authors

  • Shilpa Vaishnav Head, Department of Pathology, RRB Pathology Laboratory, Dr Hedgewar Rugnalaya, Aurangabad, Maharashtra, India.
  • Ravindra Patwadkar Consultant Pathologist, RRB Pathology Laboratory, Dr Hedgewar Rugnalaya, Aurangabad, Maharashtra, India.
  • Shridhan Patil Consultant Pathologist, RRB Pathology Laboratory, Dr Hedgewar Rugnalaya, Aurangabad, Maharashtra, India.
  • Shilpa Gatlewar Consultant Pathologist, RRB Pathology Laboratory, Dr Hedgewar Rugnalaya, Aurangabad, Maharashtra, India.
  • Priyanka Gaikwad Consultant Pathologist, RRB Pathology Laboratory, Dr Hedgewar Rugnalaya, Aurangabad, Maharashtra, India.

Keywords:

PSA Level, Various age Groups, Histopathology reports, Prostate Biopsy

Abstract

Introduction: Prostate-specific antigen (PSA) levels are difficult to interpret in all age groups, although they are used for assessing the response to prostate cancer treatment and as a screening tool for prostate cancer detection. A number of benign conditions such as Benign Prostatic hyperplastic hyperplasia and prostatitis might lead to elevated serum PSA concentrations. PSA levels lack specificity for prostate cancer detection. A biopsy is a diagnostic tool for prostate disease. The distribution of various lesions from benign to malignant varies with the different age groups.
Methods: This retrospective study was conducted for a period of one year from 01 Jan 2021 to 31 December 2021 in Smt. R.R.B. Pathology Laboratory of Dr Hedgewar Hospital, which is a tertiary care hospital in Aurangabad.
Result and Conclusion: Analysis of data suggests that the PSA level lacks specificity for prostate cancer detection. A single reading of the PSA level is not diagnostic.

How to cite this article:
Vaishnav S, Patwadkar R, Patil S, Gatlewar S, Gaikwad P. Data Analysis of PSA Levels and Age-Wise Distribution of Various Lesions Histopathological Corelation. Rec Adv Path Lab Med. 2022;8(1&2):1-3.

DOI: https://doi.org/10.24321/2454.8642.202201

References

Loeb S, Sanda MG, Broyles DL, et.al. The prostate health index selection identifies clinically significant prostate cancer. J Ura. 2015;193:1163-9.

Catalona WJ, et al -measurement of prostate-specific antigen in serum as a screening test for prostate cancer N Engl J med. 1991;324(17):1156-61.

Smith DS, Catalona WJ. The nature of prostate cancer detected through prostate-specific antigen-based screening J. Unal. 1994;152(5&2):1732-6.

Epstein JI, Grignon DJ, Humotrey PA, McNeal JE, Setsterhenn IA, Troncoso P. wiecler TM. Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia Am J surg Pathol. 1995;19(8):873-86

Safer WA, Grignon DJ, Haas GP, Heilbrun LK, Pontes JE, Crissmon JD, Age and racial distribution of prostatic intraepithelial neoplasia. Eur Vrol. 1996;30:138-144.

Downloads

Published

2022-06-30

Issue

Vol. 8 No. 1&2 (2022): Recent Advances in Pathology & Laboratory Medicine

Section

Research Article

License

Copyright (c) 2022 Recent Advances in Pathology and Laboratory Medicine ( ISSN: 2454-8642 )

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

We, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-

1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.

2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.

3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.

4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.

5. I/We also agree to the authorship of the article in the following sequence:-

Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________

Important

(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.

(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.

(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.